Tag: Discontinued drug

While the brand-name medication Phenergan was discontinued in the U.S., its active ingredient, promethazine, remains a widely used, FDA-approved prescription drug. Concerns over misuse and potential adverse effects have led to significant safety restrictions, which may lead some to question, "Is Phenergan banned in the USA?".

As of April 1, 2020, Seebri Neohaler was officially discontinued in the United States due to a strategic business decision by the product's U.S. commercial rights holder, Sunovion. The discontinuation was not a result of any safety concerns. If you are a patient previously using Seebri, it is crucial to understand the available alternatives and consult with a healthcare provider to transition your treatment effectively.

First introduced in the 1930s as a class of "miracle drugs," sulfonamides revolutionized the treatment of bacterial infections. Among these, sulfabenzamide is a sulfonamide antibacterial primarily known for its use in combination topical and intravaginal preparations, such as the now-discontinued product Sultrin. Its history and specific applications highlight the evolution of antibiotic use and the shift toward more effective and safer therapies.

In 2023, Eli Lilly Canada officially discontinued the brand-name ADHD medication Strattera. The primary reason for this phase-out was the expiration of its patent, which opened the door for generic competition and resulted in the company ceasing production of the branded version.

Teveten is the brand name for eprosartan, but this medication is no longer available in the United States, having been discontinued for business reasons, not safety concerns. This angiotensin II receptor blocker was once used to treat high blood pressure.

In clinical trials, approximately one-third of patients treated with tacrine, the active ingredient in Cognex, experienced reversible liver damage. For those interested in **what are the side effects of Cognex**, this serious issue, alongside other adverse reactions, ultimately led to the medication being withdrawn from the market.

The antihypertensive medication Guanethidine has been discontinued and is no longer available in the United States for oral use. The drug, once a frontline treatment for severe hypertension, was replaced due to significant side effects and the development of superior medications.

Despite persistent rumors, the global lactulose market is projected to continue its growth trajectory, according to recent market analysis. These market trends offer a direct and reassuring answer to those asking, **is lactulose being discontinued?** The simple explanation is that while a few specific brand-name formulations have been phased out, the generic version of the medication remains widely available for patients.

Initially approved by the FDA in 2004, Macugen (pegaptanib) was the first anti-VEGF therapy to treat wet age-related macular degeneration (AMD), and its administration was a groundbreaking medical procedure for preserving vision. This article details how is Macugen administered through a series of carefully executed intravitreal injections and explains the patient care required during treatment.

The brand-name medication Flexeril was discontinued in 2023, leaving many patients confused about their prescription. While there isn't a direct "new name for Flexeril," its active ingredient, cyclobenzaprine, is widely available as a generic drug and under newer brand names.